Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment

The actual strategy to improve current therapies in advanced prostate cancer involves targeting genes activated by androgen withdrawal, either to delay or prevent the emergence of the castration-refractory phenotype. However, these genes are often implicated in several physiological processes, and l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Ziouziou, Hajer, Andrieu, Claudia, Laurini, Erik, Karaki, Sara, Fermeglia, Maurizio, Oueslati, Ridha, Taieb, David, Camplo, Michel, Siri, Olivier, Pricl, Sabrina, Katsogiannou, Maria, Rocchi, Palma
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652782/
https://ncbi.nlm.nih.gov/pubmed/29100389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20469
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars